| TBFB+ (n = 70) count (%) median (range) | TBCB+ (n = 20) count (%) median (range) | SLB+ (n = 45) count (%) median (range) | p value | |||
---|---|---|---|---|---|---|---|
 | All | TBFB+ vs. TBCB+ | TBFB+ vs. SLB+ | TBCB+ vs. SLB+ | |||
Gender | Â | Â | Â | Â | Â | Â | Â |
 Female | 70 (100%) | 20 (100%) | 45 (100%) |  |  |  |  |
Age | 38 (20,60) | 36 (25,54) | 36 (18,61) | 0.713 | Â | Â | Â |
PaO2(Torr) | 96 (84,99) (n = 56) | 97 (86,99) (n = 20) | 97 (88,100) (n = 35) | 0.312 |  |  |  |
Smoking history | Â | Â | Â | 0.800 | Â | Â | Â |
 Never | 68 (97.1%) | 20 (100%) | 42 (97.7%) |  |  |  |  |
 Current or ex-smoker | 2 (2.9%) | 0 (0%) | 1 (2.3%) |  |  |  |  |
Past history of pneumothorax |  |  |  | 0.001 | 0.123 | 0.003 | < 0.001 |
 Yes | 27 (38.6%) | 4 (20.0%) | 29 (67.4%) |  |  |  |  |
 No | 43 (61.4%) | 16 (80.0%) | 14 (32.6%) |  |  |  |  |
Chylous effusions | 4 (5.7%) | 0 (0.0%) | 4 (5.7%) | 0.202 | Â | Â | Â |
Tuberous sclerosis complex | 3 (4.3%) | 2 (10.0%) | 2 (4.7%) | 0.639 | Â | Â | Â |
Renal angiomyolipoma | 10 (14.3%) | 7 (35.0%) | 6 (14.0%) | 0.109 | Â | Â | Â |
Number of specimens | 5.5 (4,10) n = 20 | 4 (3,5) n = 12 |  |  | 0.016 |  |  |
%predicted DLco | 42.50 (18.00,119.00) n = 54 | 50.00 (24.00.94.80) n = 19 | 56.00 (12.00,97.00) n = 25 | 0.384 |  |  |  |
%predicted FEV1 | 58.00 (14.50,105.10) n = 55 | 77.00 (23.60,138.70) n = 20 | 62.00 (18.00,99.60) n = 31 | 0.259 |  |  |  |
FEV1/FVC | 58.52 (21.03,99.61) n = 55 | 70.40 (22.74,87.10) n = 20 | 76.62 (36.80,98.68) n = 31 | 0.030 | 0.740 | 0.030 | 0.360 |
%predicted TLC | 101.50 (64.00,138.90) n = 50 | 105.00 (84.00,142.50) n = 19 | 89.15 (59.10,124.80) n = 22 | 0.013 | 0.999 | 0.036 | 0.020 |
%predicted RV | 125.05 (67.00,326.20) n = 50 | 127.00 (58.00,257.80) n = 19 | 117.00 (74.00,254.00) n = 22 | 0.736 |  |  |  |
RV/TLC | 39.60 (22.58,77.18) n = 50 | 38.80 (17.50,65.57) n = 19 | 39.95 (28.80,68.88) n = 22 | 0.634 |  |  |  |